US EditionMetformin Activates Tumor-Fighting T Cells in Mice, Suggesting Potential Role in Cancer Immunotherapy - Gilmore Health News
Summary by Gilmore Health News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Metformin Activates Tumor-Fighting T Cells in Mice, Suggesting Potential Role in Cancer Immunotherapy - Gilmore Health News
Key Takeaways Metformin boosted CD8+ T cell activity in mice by increasing mitochondrial ROS and promoting immune cell growth. The anti-tumor effect wasn’t due to apoptosis, but to immune system modulation via interferon-γ secretion. Findings are preclinical — no human data yet, and the study didn’t test interactions with real-world cancer treatments. A team of Okayama University scientists just helped shed light on an often proposed but poorly…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
